Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.

被引：14
作者：
Huerta M.G. [1 ]
Nadler J.L. [1 ]
机构：
[1] 1st Floor Room #1220, Division of Endocrinology and Metabolism, University of Virginia, Fontaine Research Park, Fontaine Medical Research Building, P.O. Box 801405, 450 Ray C. Hunt Drive, Charlottesville, 22908-1405, VA
来源：
Current Diabetes Reports | 2002年 / 2卷 / 5期
关键词：
Pravastatin; Ramipril; Troglitazone; Early Atherosclerotic Lesion; Insulin Resistance Atherosclerosis Study;
D O I：
10.1007/s11892-002-0103-5
中图分类号：
学科分类号：
摘要：
Experimental and epidemiologic studies support the role of inflammation in the development of type 2 diabetes and atherosclerosis. Serum levels of inflammatory markers, in particular highly sensitive C-reactive protein, have been found to be strong predictors of increased risk for type 2 diabetes and cardiovascular disease independent of traditional risk factors. A beneficial effect of thiazolidinediones, angiotensin-converting enzyme inhibitors, and statins in the prevention of type 2 diabetes and cardiovascular events has recently been reported, and potential anti-inflammatory mechanisms of action for these compounds have been described. Prospective, randomized clinical trials are currently underway to confirm these initial findings and define indications for treatment of patients at risk.
引用
收藏
页码：396 / 402
页数：6
相关论文
共 152 条
[11]  
Li C(1997)Protection from obesity-induced insulin resistance in mice lacking TNF alpha function Nature 389 610-614
[12]  
Bastard JP(2001)Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance Eur J Endocrinol 145 273-280
[13]  
Jardel C(1999)Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study Lancet 353 1649-1652
[14]  
Bruckert E(1995)Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes Am J Physiol 269 E323-E330
[15]  
Visser M(2001)The relation of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study Diabetes 50 2384-2389
[16]  
Bouter LM(2002)Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study Diabetes 51 1131-1137
[17]  
McQuillan GM(1999)Novel inflammatory markers of coronary risk: theory versus practice Circulation 100 1148-1150
[18]  
Yudkin JS(2001)Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study Circulation 103 357-362
[19]  
Stehouwer CDA(1999)Inhibition of proinflammatory cytokine production by pravastatin Lancet 353 983-984
[20]  
Emeis JJ(2001)Ramipril and the development of diabetes JAMA 286 1882-1885
12345678910